Nano Holdings
4571.TTSE GROWTHPharmaceutical
Filed as NanoCarrier Co., Ltd. (2022-06–2023-02), NANO MRNA Co., Ltd. (2023-06–2025-11)
Financials · Consolidated
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|---|
| Revenue | ¥174m | ¥109m | ¥136m | ¥202m | — |
| Operating income | −¥966m | −¥755m | −¥864m | −¥1.2bn | — |
| Ordinary income | −¥867m | −¥688m | −¥750m | −¥1.1bn | — |
| Net income (owners) | −¥944m | −¥835m | −¥780m | −¥1.3bn | — |
| Total assets | ¥5.9bn | ¥4.0bn | ¥5.1bn | ¥5.8bn | — |
| Net assets / equity | ¥3.6bn | ¥2.7bn | ¥3.4bn | ¥4.3bn | ¥5.6bn |
| Operating cash flow | −¥817m | −¥402m | −¥585m | −¥1.1bn | — |
| EPS (basic) | ¥-12.9 | ¥-11.85 | ¥-11.1 | ¥-18.7 | — |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 2
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2025-09-30 | Half-year | 67 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 67 figures · EDINET |
22 more reports are still being processed.